Miswired enhancer logic drives translocation positive rhabdomyosarcoma
B. E. Gryder, M. Wachtel, K. Chang, O. E. Demerdash, N. G. Aboreden, W. Ewert, S. Pomella, W. Mohammed, R. Rota, J. S. Wei, Y. Song, B. Schaefer, C. R. Vakoc, J. Khan
Abstract
Core regularity transcription factors (CR TFs) define cell identity and lineage through an exquisitely precise and logical order during embryogenesis and development. These CR TFs regulate one another in three-dimensional space via distal enhancers that serve as logic gates embedded in their TF recognition sequences. Aberrant chromatin organization resulting in miswired circuitry of enhancer logic is a newly recognized feature in many cancers. Here, we report that PAX3-FOXO1 expression is driven by a translocated FOXO1 distal super enhancer (SE). Using 4C-seq, a technique detecting all genomic regions that interact with the translocated FOXO1 SE, we demonstrate its physical interaction with the PAX3 promotor only in the presence of the oncogenic translocation. Furthermore, RNA-seq and ChIP-seq in tumors bearing rare PAX translocations implicate enhancer miswiring is a pervasive feature across all FP-RMS tumors. HiChIP of enhancer mark H3K27ac showed extended connectivity between the distal FOXO1 SE and additional intra-domain enhancers and the PAX3 promoter. We show by CRISPR-paired-ChIP-Rx that PAX3-FOXO1 transcription is diminished when this network of enhancers is selectively ablated. Therefore, our data reveal a mechanism of a translocated hijacked enhancer which disrupts the normal CR TF logic during skeletal muscle development (PAX3 to MYOD to MYOG), replacing it with an infinite loop logic that locks rhabdomyosarcoma cells in an undifferentiated proliferating stage.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo
Jack P. Kucinski, Alexi M Tallan, … Genevieve C. Kendall·Cell ReportsPeer-reviewed·Jul 1, 2025
- Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs
L. MANCEAU, J. RICHARD ALBERT, … V. Ribes·bioRxiv·Aug 18, 2021
- Myogenic and neural transcriptional circuitry determines PAX3::FOXO1 driven initiation of rhabdomyosarcoma
Bradley T. Stevens, Yang Zhang, … Mark E. Hatley·bioRxiv·Oct 29, 2026
- USP7 sustains PAX3::FOXO1 enhancer reprogramming and represents a therapeutic vulnerability in Rhabdomyosarcoma
Pablo Táboas, Enrique Blanco, … Sara Sánchez-Molina·bioRxiv·Jun 8, 2026
- Fusion transcription factor dosage controls cell state in rhabdomyosarcoma
Rachel A. Hoffman, Meng Wang, … Benjamin Z. Stanton·bioRxiv·May 16, 2025
- Comparative modes of chromatin engagement by PAX::FOXO1 fusions in rhabdomyosarcoma
Alexi M Tallan, Jack P. Kucinski, … Benjamin Z. Stanton·bioRxiv·Feb 19, 2026